Profile
Nina C.
Thayer is currently the Chief Compliance Officer & General Counsel at GreenLight Biosciences Holdings PBC.
Previously, she worked as an Associate at Goodwin Procter LLP.
From 2015 to 2021, she held the positions of Secretary, Associate General Counsel & VP at Allied Minds Plc.
In 2021 to 2022, she served as the Vice President-Legal Affairs at Gemini Therapeutics Sub, Inc. Ms. Thayer completed her undergraduate studies at Boston University and obtained her graduate degree from Boston University School of Law.
Nina Thayer active positions
| Companies | Position | Start |
|---|---|---|
| GREENLIGHT BIOSCIENCES HOLDINGS | Compliance Officer | 01/03/2023 |
Former positions of Nina Thayer
| Companies | Position | End |
|---|---|---|
Gemini Therapeutics Sub, Inc.
Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | General Counsel | 01/12/2022 |
| ALLD MIND | General Counsel | - |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | - |
Training of Nina Thayer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Boston University School of Law
Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allied Minds Plc
Allied Minds Plc Investment ManagersFinance Invests in technology and life sciences companies | Finance |
Gemini Therapeutics Sub, Inc.
Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
GreenLight Biosciences Holdings PBC
GreenLight Biosciences Holdings PBC BiotechnologyHealth Technology Operates as a biotechnology company that develops ribonucleic acid products | Health Technology |
- Stock Market
- Insiders
- Nina Thayer
















